Table 1.

Summary of the key metabolites driving the discrimination between treatment groups, and their direction of change compared to saline.

Key plasma metabolites	Direction of change (LPS vs Saline)
–CH3 mobile lipoprotein (HDL)	↓**
–CH3 mobile lipoprotein (VLDL)	↓*
Isoleucine	↑***
Isoleucine/Leucine	↑***
(–CH2–)n mobile lipoprotein	↓**
α-glucose	↓***
β-glucose	↓***
Creatine	↑*

HDL high density lipoprotein, VLDL very low density lipoprotein *p < 0.05; **p < 0.01; ***p < 0.001.